GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Join us this August for LEAP HR: Life Sciences East for its 9th year in Boston, MA to network with 200+ senior HR leaders ...

TriSalus Life Sciences expects 50% sales growth and EBITDA positivity in 2025. See why TLSI stock could benefit, with key ...

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

These could revolutionize medical research and drug development, greatly reducing ... We have an innate respect for human life in all its forms. We do not allow broad research on people who ...

AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal investigations.

NeOnc Technologies Holdings, Inc. (NASDAQ Global Market: NTHI), a clinical-stage medical biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare ...

In this week’s edition of the biotech bi-weekly, learn more about Thermo Fisher’s new system for automating complex sample ...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the fourth quarter and full-year ended December 31, 2024, and ...